The effective perospirone augmentation with clonazepam for treatment‐resistant burning mouth syndrome: A case report
Neuropsychopharmacology Reports · 2024
DOI: 10.1002/npr2.12425 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Motoko Watanabe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Hauptthemen laut MEDLINE: Clonazepam, Burning Mouth Syndrome, Drug Therapy, Combination, Isoindoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Burning mouth syndrome (BMS) is characterized by burning sensations in the oral region without corresponding abnormalities and is often accompanied by uncomfortable sensations. Herein, we present cases of BMS in which the remaining uncomfortable sensations improved with perospirone augmentation with clonazepam. Case 1: A 61‐year‐old man complained of a burning pain in his tongue, a sensation of dryness and discomfort as if his tongue was sticking to a palatal plate. With the diagnosis of BMS, psychopharmacotherapy was initiated with amitriptyline. At the dose of amitriptyline 50 mg, the pain lessened but uncomfortable sensations persisted. Further attempts to alleviate symptoms by combining aripiprazole with amitriptyline, aripiprazole with mirtazapine, or aripiprazole with clonazepam were limited; however, nearly all symptoms were relieved by a combination of perospirone 8.0 mg with clonazepam 1.5 mg. Case 2: A 51‐year‐old woman complained of a burning sensation along with oral dryness and crumb‐like feeling on her tongue. She was diagnosed with BMS and began treatment with amitriptyline. Her burning sensation improved at the dose of 25 mg, but uncomfortable sensations persisted. Augmentation of amitriptyline with aripiprazole, aripiprazole either with valproate, mirtazapine, or clonazepam failed to produce a significant improvement. However, a regimen of perospirone 6.0 mg and clonazepam 1.5 mg relieved the crumb‐like sensation and pain and culminated in a stabilized condition. The reported cases suggested that multiple approaches targeting the dopaminergic circuit in basal ganglia involving the serotoninergic and GABA systems, through the administration of perospirone with clonazepam is an effective adjunctive treatment for the remaining uncomfortable sensations in patients with BMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
- Department of Basic Dental Sciences, Faculty of Odonto-stomatology, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam.
- Department of Psychiatric Internal Medicine, Sunlight Brain Research Center, Yamaguchi, Japan.
ORCID-Profile: Motoko Watanabe, Chihiro Takao, Chizuko Maeda, Gayatri Nayanar, Risa Tominaga, Yasuyuki Kimura, Trang Thi Huyen Tu, Takahiko Nagamine, Akira Toyofuku
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Watanabe, M., Takao, C., Maeda, C., Nayanar, G., Tominaga, R., Kimura, Y., Tu, T. T. H., Nagamine, T., & Toyofuku, A. (2024). The effective perospirone augmentation with clonazepam for treatment‐resistant burning mouth syndrome: A case report. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12425
Vancouver
Watanabe M, Takao C, Maeda C, Nayanar G, Tominaga R, Kimura Y, et al. The effective perospirone augmentation with clonazepam for treatment‐resistant burning mouth syndrome: A case report. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12425
BibTeX
@article{Watanabe2024,
author = {Watanabe, Motoko and Takao, Chihiro and Maeda, Chizuko and Nayanar, Gayatri and Tominaga, Risa and Kimura, Yasuyuki and Tu, Trang Thi Huyen and Nagamine, Takahiko and Toyofuku, Akira},
title = {The effective perospirone augmentation with clonazepam for treatment‐resistant burning mouth syndrome: A case report},
journal = {Neuropsychopharmacology Reports},
year = {2024},
doi = {10.1002/npr2.12425}
}
EUVIMED